116 related articles for article (PubMed ID: 32314875)
1. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
[TBL] [Abstract][Full Text] [Related]
2. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
[TBL] [Abstract][Full Text] [Related]
3. Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
Ranjan S; Leung D; Ghiaseddin AP; Taylor JW; Lobbous M; Dhawan A; Budhu JA; Coffee E; Melnick K; Chowdhary SA; Lu-Emerson C; Kurz SC; Burke JE; Lam K; Patel MP; Dunbar EM; Mohile NA; Peters KB
Cancer; 2024 May; 130(9):1577-1589. PubMed ID: 38288941
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism in pregnant patients with active malignancy: A systematic review and meta-analysis.
Folkins S; Miller A; Nash CM
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):645-652. PubMed ID: 37968882
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
Res Pract Thromb Haemost; 2020 Jul; 4(5):860-865. PubMed ID: 32685895
[TBL] [Abstract][Full Text] [Related]
6. Acute venous thromboembolism in patients with brain cancer: clinical course.
Becattini C; Giustozzi M; Portillo J; Fernández-Capitán C; Lobo JL; Peris ML; Font C; Grange C; Weinberg I; Monreal M;
Res Pract Thromb Haemost; 2023 Aug; 7(6):102172. PubMed ID: 37810416
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
Dasgupta P; Rousseau JF
J Neurooncol; 2024 Feb; 166(3):569-574. PubMed ID: 38286976
[TBL] [Abstract][Full Text] [Related]
8. Comment on "Venous thromboembolism after spontaneous intracerebral hemorrhage and the status quo of anticoagulation in this population: A retrospective case-control study from a tertiary hospital in China".
Ansari Z; Rafiq Y; Arif H; Shahid F
Clin Neurol Neurosurg; 2023 Oct; 233():107954. PubMed ID: 37689013
[No Abstract] [Full Text] [Related]
9. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
Dasgupta P; Ou A; Lin H; Gregory T; Alfaro-Munoz KD; Yuan Y; Afshar-Khargan V; Kamiya-Matsuoka C; Rousseau JF; Majd NK
J Neurooncol; 2024 Mar; 167(1):181-188. PubMed ID: 38372903
[TBL] [Abstract][Full Text] [Related]
10. An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism.
Martins MA; Silva TF; Fernandes CJ
Curr Oncol Rep; 2023 May; 25(5):425-432. PubMed ID: 36928825
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors.
Ma S; Patell R; Miller E; Ren S; Marquez-Garcia J; Panoff S; Sharma R; Pinson A; Elavalakanar P; Weber G; Uhlmann E; Neuberg D; Soman S; Zwicker JI
J Thromb Haemost; 2023 May; 21(5):1148-1155. PubMed ID: 36740041
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients' and Clinicians' Awareness.
Zalunardo B; Panzavolta C; Bigolin P; Visonà A
Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295029
[TBL] [Abstract][Full Text] [Related]
13. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D; Frere C; Connors JM; Khorana AA; Kakkar A; Ay C; Muñoz A; Brenner B; Prata PH; Brilhante D; Antic D; Casais P; Guillermo Esposito MC; Ikezoe T; Abutalib SA; Meillon-García LA; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2022 Jul; 23(7):e334-e347. PubMed ID: 35772465
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation and bleeding in the cancer patient.
Escobar A; Salem AM; Dickson K; Johnson TN; Burk KJ; Bashoura L; Faiz SA
Support Care Cancer; 2022 Oct; 30(10):8547-8557. PubMed ID: 35579752
[TBL] [Abstract][Full Text] [Related]
15. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
[TBL] [Abstract][Full Text] [Related]
16. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.
Kaptein FHJ; Stals MAM; Kapteijn MY; Cannegieter SC; Dirven L; van Duinen SG; van Eijk R; Huisman MV; Klaase EE; Taphoorn MJB; Versteeg HH; Buijs JT; Koekkoek JAF; Klok FA
J Thromb Haemost; 2022 Jul; 20(7):1665-1673. PubMed ID: 35460331
[TBL] [Abstract][Full Text] [Related]
17. Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional Analysis.
Ehret F; Kaul D; Mose L; Budach V; Vajkoczy P; Fürweger C; Haidenberger A; Muacevic A; Mehrhof F; Kufeld M
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158734
[TBL] [Abstract][Full Text] [Related]
18. Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?
Taylor JW
Neuro Oncol; 2022 Mar; 24(3):465-466. PubMed ID: 34850168
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
